MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 21, 2005; DOI: 10.1124/mol.104.008367


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.008367v1
68/4/1018    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, W. J.
Right arrow Articles by Zhu, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, W. J.
Right arrow Articles by Zhu, B. T.


Received for publication October 15, 2004.
Revised July 21, 2005.
Accepted for publication July 21, 2005.

Mechanisms for the Inhibition of DNA Methyltransferases by Tea Catechins and Bioflavonoids

Won Jun Lee 1, Joong-Youn Shim 2, Bao Ting Zhu 1*

1 Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of South Carolina 2 J. L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University

* Address correspondence to: E-mail: btzhu{at}cop.sc.edu

Abstract

In the present investigation, we studied the modulating effects of several tea catechins and bioflavonoids on the DNA methylation catalyzed by prokaryotic SssI DNA methyltransferase (DNMT) and human DNMT1. We found that each of the tea polyphenols (catechin, epicatechin, and [-]-epigallocatechin-3-O-gallate [EGCG]) and bioflavonoids (quercetin, fisetin, and myricetin) inhibited SssI DNMT- and DNMT1-mediated DNA methylation in a concentration-dependent manner. The IC50 values for catechin, epicatechin, and various flavonoids ranged from 1.0 - 8.4 µM, but EGCG was a more potent inhibitor, with IC50 values at 0.21 - 0.47 µM. When epicatechin was used as a model inhibitor, kinetic analyses showed that this catechol-containing dietary polyphenol inhibited enzymatic DNA methylation in vitro largely through increased formation of S-adenosyl-L-homocysteine (a potent noncompetitive inhibitor of DNMTs) during the catechol-O-methyltransferase-mediated O-methylation of this dietary catechol. In comparison, the strong inhibitory effect of EGCG on DNMT-mediated DNA methylation was independent of its own methylation, and it is largely due to its direct inhibition of the DNMTs. This inhibition is strongly enhanced by Mg2+. Computational modeling studies showed that the gallic acid moiety of EGCG plays a crucial role in its high-affinity, direct inhibitory interaction with the catalytic site of the human DNMT1, and its binding with the enzyme is stabilized by Mg2+. The modeling data on the precise molecular mode of EGCG's inhibitory interaction with human DNMT1 agrees perfectly with our experimental finding.


Key words: Mechanisms of cell killing/apoptosis, Tumor suppressors





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics